Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

1.79
Delayed Data
As of Dec 02
 +0.04 / +2.29%
Today’s Change
1.40
Today|||52-Week Range
4.05
-37.85%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close1.75
Today’s open1.76
Day’s range1.73 - 1.81
Volume82,754
Average volume (3 months)422,692
Market cap$46.7M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+9.72%
Earnings growth (this year)+1.54%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
AVEOAveo Pharmaceuticals...+0.01+1.64%
CHMAChiasma Inc-0.05-2.63%
RPRXRepros Therapeutics ...+0.01+0.57%
MTEXMannatech Inc+0.35+2.15%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$0.00
Annual profit (last year)-$24.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs